These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32007593)

  • 1. Effects of different resistance mechanisms on antimicrobial resistance in Acinetobacter baumannii: a strategic system for screening and activity testing of new antibiotics.
    Tsai YK; Liou CH; Lin JC; Fung CP; Chang FY; Siu LK
    Int J Antimicrob Agents; 2020 Apr; 55(4):105918. PubMed ID: 32007593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
    Rumbo C; Gato E; López M; Ruiz de Alegría C; Fernández-Cuenca F; Martínez-Martínez L; Vila J; Pachón J; Cisneros JM; Rodríguez-Baño J; Pascual A; Bou G; Tomás M; ; ;
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5247-57. PubMed ID: 23939894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
    Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
    Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii.
    Esterly JS; Richardson CL; Eltoukhy NS; Qi C; Scheetz MH
    Ann Pharmacother; 2011 Feb; 45(2):218-28. PubMed ID: 21304033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of the novel fluorocycline eravacycline against carbapenem non-susceptible Acinetobacter baumannii.
    Seifert H; Stefanik D; Sutcliffe JA; Higgins PG
    Int J Antimicrob Agents; 2018 Jan; 51(1):62-64. PubMed ID: 28705668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
    Lee SY; Oh MH; Yun SH; Choi CW; Park EC; Song HS; Lee H; Yi YS; Shin J; Chung C; Moon JY; Lee JC; Kim GH; Kim SI
    Infect Genet Evol; 2018 Nov; 65():150-158. PubMed ID: 30053642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Aminoglycoside Resistance Due to armA methylase in Multi-drug Resistant Acinetobacter Baumannii Isolates in a University Hospital in Nepal.
    Shrestha S; Tada T; Shrestha B; Kirikae T; Ohara H; Rijal BP; Pokhrel BM; Sherchand JB
    J Nepal Health Res Counc; 2016 May; 14(33):72-76. PubMed ID: 27885285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of 16S rRNA methylase ArmA-producing Acinetobacter baumannii and rapid spread of metallo-β-lactamase NDM-1 in Algerian hospitals.
    Bakour S; Touati A; Bachiri T; Sahli F; Tiouit D; Naim M; Azouaou M; Rolain JM
    J Infect Chemother; 2014 Nov; 20(11):696-701. PubMed ID: 25240726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CraA, a major facilitator superfamily efflux pump associated with chloramphenicol resistance in Acinetobacter baumannii.
    Roca I; Marti S; Espinal P; Martínez P; Gibert I; Vila J
    Antimicrob Agents Chemother; 2009 Sep; 53(9):4013-4. PubMed ID: 19581458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
    Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
    Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Acinetobacter baumannii clinical isolates carrying bla(OXA-23) carbapenemase and 16S rRNA methylase armA genes in Yemen.
    Bakour S; Alsharapy SA; Touati A; Rolain JM
    Microb Drug Resist; 2014 Dec; 20(6):604-9. PubMed ID: 24901296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of blaOXA-23 with armA in quinolone-resistant Acinetobacter baumannii from a Chinese university hospital.
    Shen M; Luan G; Wang Y; Chang Y; Zhang C; Yang J; Deng S; Ling B; Jia X
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):230-1. PubMed ID: 26740313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
    Lin MF; Lin YY; Tu CC; Lan CY
    J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics.
    Fernando DM; Xu W; Loewen PC; Zhanel GG; Kumar A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6424-31. PubMed ID: 25136007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-drug resistance profiles and the genetic features of Acinetobacter baumannii isolates from Bolivia.
    Lopes BS; Gallego L; Amyes SG
    J Infect Dev Ctries; 2013 Apr; 7(4):323-8. PubMed ID: 23592642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct role of outer membrane protein A in the intrinsic resistance of Acinetobacter baumannii and Acinetobacter nosocomialis.
    Kwon HI; Kim S; Oh MH; Shin M; Lee JC
    Infect Genet Evol; 2019 Jan; 67():33-37. PubMed ID: 30385392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii.
    Leus IV; Weeks JW; Bonifay V; Smith L; Richardson S; Zgurskaya HI
    J Bacteriol; 2018 Jul; 200(13):. PubMed ID: 29661860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of fluoroquinolone resistance mechanisms in clinical Acinetobacter baumannii isolates].
    Güler G; Eraç B
    Mikrobiyol Bul; 2016 Apr; 50(2):278-86. PubMed ID: 27175500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
    Karah N; Dwibedi CK; Sjöström K; Edquist P; Johansson A; Wai SN; Uhlin BE
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1801-18. PubMed ID: 26824943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.